Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy

BACKGROUND: Although CD4 cell count monitoring is used to decide when to start antiretroviral therapy in patients with HIV-1 infection, there are no evidence-based recommendations regarding its optimal frequency. It is common practice to monitor every 3 to 6 months, often coupled with viral load mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Buclin, Thierry, Telenti, Amalio, Perera, Rafael, Csajka, Chantal, Furrer, Hansjakob, Aronson, Jeffrey K., Glasziou, Paul P.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072996/
https://www.ncbi.nlm.nih.gov/pubmed/21494630
http://dx.doi.org/10.1371/journal.pone.0018578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072996/
https://www.ncbi.nlm.nih.gov/pubmed/21494630
http://dx.doi.org/10.1371/journal.pone.0018578

Ejemplares similares